D

Vext Science, Inc. VEXTF

OTC PK
Recommendation
Dividend Power Score
Day's Range
$0.12$0.13
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

Company Overview

Vext Science, Inc. is a cannabis operator focused on the cultivation, manufacturing, distribution, and retail sale of cannabis products in the United States. The company operates primarily in the regulated medical and adult-use cannabis sectors, with a concentration in Arizona and Ohio. Vext Science generates revenue through vertically integrated cannabis operations that include cultivation facilities, extraction and manufacturing capabilities, wholesale distribution, and retail dispensaries. Its operations are structured to participate across multiple points of the cannabis value chain, including branded products and dispensary sales.

The company’s core business has historically centered on its Vapen branded cannabis products, which include concentrates, cartridges, edibles, and related cannabis derivatives. Vext Science has positioned itself as a multi-state operator with an emphasis on operational efficiency, local market scale, and controlled production infrastructure in limited-license markets. The company evolved through acquisitions, licensing arrangements, and state-level expansion initiatives following the broader legalization trend in U.S. cannabis markets. Public disclosures and regulatory filings indicate that the company has focused on maintaining a lean operating structure while expanding selectively in states with constrained licensing environments.

Business Operations

Vext Science conducts operations through vertically integrated cannabis assets that include cultivation, processing, extraction, manufacturing, wholesale distribution, and retail dispensaries. Its primary operating footprint has been concentrated in Arizona, where the company has maintained cultivation and manufacturing assets tied to the Vapen product line, alongside retail dispensary interests. The company has also pursued operations and investment activity in Ohio, a market viewed as strategically important due to evolving adult-use legalization and medical cannabis demand.

The company controls cannabis production and processing infrastructure that supports branded product manufacturing and third-party wholesale relationships. Vext Science has historically operated through subsidiaries and state-licensed entities that hold cultivation, manufacturing, and retail licenses. Public filings reference strategic relationships and acquisitions tied to dispensary operations and cannabis production assets, although some ownership structures and operational arrangements may vary by state due to regulatory requirements. Data regarding certain partnership structures and non-controlling interests is limited or subject to changing state-level disclosures.

Strategic Position & Investments

Vext Science’s strategic direction has emphasized disciplined expansion in limited-license cannabis markets, operational integration, and margin-focused growth. The company has pursued investments in cultivation capacity, extraction technologies, and retail distribution channels intended to strengthen brand penetration and improve supply-chain control. Management commentary in public filings has also highlighted efforts to increase exposure to higher-growth regulated cannabis markets while maintaining capital efficiency.

The company has completed acquisitions and investments associated with cannabis dispensaries and production facilities, particularly in Arizona and Ohio. Vext Science has also maintained a strategic focus on branded cannabis products under the Vapen label and related derivative categories. Its investment strategy appears oriented toward scalable cannabis infrastructure and selective market expansion rather than rapid national footprint growth. Public information confirms participation in regulated cannabis manufacturing and retail operations, though some details regarding future expansion projects remain dependent on regulatory approvals and market conditions.

Geographic Footprint

Vext Science is headquartered in Canada and operates primarily in the United States, with its most significant operational presence in Arizona and developing interests in Ohio. The company’s operational model is concentrated in state-regulated cannabis markets where vertically integrated licenses can support cultivation, manufacturing, and retail activities within a single jurisdiction. Its market exposure has therefore been more regionally concentrated than larger multi-state cannabis operators.

The company’s activities are tied to North American cannabis markets, with revenue primarily generated from U.S. cannabis operations despite its Canadian corporate structure and public market presence. Vext Science has participated in regulated cannabis markets through state-specific subsidiaries and licensed operating entities. Public disclosures indicate that its geographic strategy has prioritized operational depth within targeted jurisdictions rather than broad international expansion.

Leadership & Governance

Vext Science’s leadership team has focused on operational execution, disciplined capital allocation, and strategic participation in limited-license cannabis markets. The company’s governance structure reflects a typical publicly traded cannabis operator model, with executive oversight spanning finance, operations, legal compliance, and market expansion. Management communications and investor materials have consistently emphasized profitability, vertical integration, and selective growth opportunities within regulated U.S. cannabis markets.

Key executives publicly associated with the company include:

  • Eric Offenberger – Chief Executive Officer
  • Peter McDonough – Chief Financial Officer
  • Terry Booth – Director and strategic advisor involvement has been referenced in public disclosures
  • Julie Dennis – Corporate Secretary and governance-related executive functions have been referenced in filings

Certain executive roles and board compositions have changed over time through corporate restructuring and public company governance updates. Data regarding some historical leadership appointments is inconclusive based on available public sources.

Data compiled by narrative technology. May contain errors.

Top Tech Stocks
See All »
B
AAPL NASDAQ $342.56
B
MSFT NASDAQ $484.52
B
NVDA NASDAQ $125.53
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $127.95
B
A
Top Financial Stocks
See All »
A
B
JPM NYSE $310.53
B
V NYSE $401.87
Top Energy Stocks
See All »
B
CVX NYSE $208.37
B
COP NYSE $136.12
Top Health Care Stocks
See All »
B
LLY NYSE $1,347.11
B
JNJ NYSE $270.47
B
ABBV NYSE $286.20
Top Real Estate Stocks
See All »
B
PLD NYSE $122.50